The diagnosis and treatment of canine and feline lymphoma is evolving rapidly. Advanced pathological subtyping of lymphoma has expanded our knowledge of a heterogenous disease, but have our treatment options matched pace? This virtual, day-long course will review the genetics of lymphoma development, and how that correlates with pathological and immunophenotypic subtyping. New treatment opportunities and challenges will be explored including the use of bone marrow transplants, half-body radiation therapy, monoclonal antibodies, and precision medicine. This course will include presentations by leaders in veterinary oncology, panel discussions, and opportunities for audience engagement.